Hypertension Trial, Recruiting NCT05000515 Sponsor: University of Colorado, Boulder Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT05000515
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women who have been through menopause, with no menstrual period for more than 12 months
  • Women who have not used any hormone therapies in the past 12 months
  • Women aged 50 years or older
  • People who are able to give informed consent to participate
  • People who are willing to be randomly assigned to a study group
  • People whose resting blood pressure (the top number) is 120 mmHg or higher
  • People with a body mass index (a measure of body weight relative to height) below 40
  • People whose weight has been stable (changed by less than 2 kg) in the past 3 months, and who are willing to keep their weight stable throughout the study
  • People whose blood pressure medications and other medications have not changed in the past 3 months, and who are willing to keep their medication routine the same during the study
  • People who are generally in good health, except for having high blood pressure

Who may not be able to join:

  • People younger than 50 years of age
  • People who went through menopause before age 45
  • People who have had a hysterectomy (surgical removal of the uterus)
  • People with a history of severely uncontrolled high blood pressure (top number above 180 mmHg and/or bottom number above 120 mmHg)
  • People who currently smoke
  • People with alcohol dependence or misuse
  • People whose blood pressure responds abnormally during exercise (confirm with trial site for specific details)
  • People who already do regular intense aerobic or endurance exercise more than 4 times per week, for more than 30 minutes at a time, at a high level of effort

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Douglas R Seals, PhD, University of Colorado, Boulder

Phone: 303-492-3010

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Colorado, Boulder
Registry
ClinicalTrials.gov
Start date
19 April 2022
Est. completion
28 February 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change from baseline in casual systolic and diastolic blood pressure at 3 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov